Porphyrins show improved phototoxicity in cancer cell lines, suggesting potential for effective G4-targeting photodynamic therapy.
Porphyrins are well-known photosensitizers (PSs), a few of which are clinically approved drugs for use in photodynamic therapy (PDT). Porphyrin derivatives include tetra-cationic porphyrins, e.g. TMPyP4, are also well-studied binders...
No takes yet. Share an insight, caveat, or question.
Çeli̇k et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: